Cell line · CVCL_0426
MG-63
Cancer cell line, Homo sapiens. Osteosarcoma. 81 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. MG-63. Cell lines, record CVCL_0426. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0426
On this page
Cell line
As Cellosaurus gives it.
- Name
- MG-63
- Accession
- CVCL_0426
- RRID
- RRID:CVCL_0426
- Synonyms
- M-G63, MG63
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 14Y
- Category
- Cancer cell line
- Diseases
- Osteosarcoma (NCIt C9145); Osteosarcoma (ORDO Orphanet_668)
- Derived from
- Bone, left femur (metastatic)
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems1
| Problem | Cellosaurus's note |
|---|---|
| Caution | The reported STR profile from CLS of this cell line was changed in June 2019. Seven conflicts with other sources were resolved. |
Source Cellosaurus
Papers81
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Surface modification of 3D‐printed polycaprolactone scaffolds with silk fibroin for bone tissue engineering | FEBS Open Bio | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Exosomal CircRNA_102619-miR-330-3p Interaction Regulates Osteosarcoma Progression and Metastasis by Forming the Lung Pre-Metastatic Niche. | Int J Mol Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| An inertial-based spiral device for separating rare tumor cells from liquid biopsies. | Bioeng Transl Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Inference of lineage hierarchies, growth, and drug response mechanisms in cancer cell populations without tracking. | Cell Rep Methods | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Vitamin D decreases tumor cell growth and invasiveness in primary malignant bone tumors in vitro. | J Bone Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Combined treatment using repurposed synthetic peptide desmopressin and bevacizumab as a potential antiangiogenic strategy in osteosarcoma. | Front Med (Lausanne) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Prognostic characteristics of disulfidptosis-related genes across cancers and their potential implications in osteosarcoma. | Sci Prog | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Ldha Regulates Osteosarcoma Lung Metastasis through Hedgehog Signaling. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Molecular mechanism of miR-27a-3p targeting FBXW7 regulating the malignant behavior of osteosarcoma cells. | Transl Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Combined Inhibition of ATR and Ribonucleotide Reductase Induces Synergistic Antineoplastic Activity in Osteosarcoma Cells. | Cancer Rep (Hoboken) | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 81
See all 81 papersRelatives11
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | MG-63-GAS-Luc2 | CVCL_C9CX | Cell lines | |
| Derived from it | MG-63.3A | CVCL_IR36 | Cell lines | |
| Derived from it | MG-63/CISR8 | CVCL_C6UW | Cell lines | |
| Derived from it | MG-63/DOXR8 | CVCL_C6UX | Cell lines | |
| Derived from it | MG-63/MTXR8 | CVCL_C6UY | Cell lines | |
| Derived from it | MG-63/TRIR8 | CVCL_C6UZ | Cell lines | |
| Derived from it | MG63.2 | CVCL_R705 | Cell lines | |
| Derived from it | MG63/DXR1000 | CVCL_9U34 | Cell lines | |
| Derived from it | OSE-MG63 | CVCL_WR53 | Cell lines | |
| Derived from it | Ubigene MG-63 CD276 KO | CVCL_E0Z3 | Cell lines |
1 to 10 of 11
See all 11 relativesCell banks15
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRL-1427 | ATCC | |
| AddexBio | C0004007/4991 | Cellosaurus | |
| BCRC | 60279 | BCRC | |
| BCRJ | 0173 | BCRJ | |
| CCTCC | GDC0074 | Cellosaurus | |
| CLS | 300441 | CLS | |
| ECACC | 86051601 | ECACC | |
| ICLC | HTL99003 | ICLC | |
| IZSLER | BS TCL 40 | Cellosaurus | |
| JCRB | IFO50108 | JCRB |
1 to 10 of 15
See all 15 cell banksData dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0426
GET https://conductscience.org/api/cell-lines/v1/CVCL_0426/papers?page=2